1b0w: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,068 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,068 edits
No edit summary
Line 1: Line 1:
[[Image:1b0w.gif|left|200px]]
{{Seed}}
[[Image:1b0w.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1b0w|  PDB=1b0w  |  SCENE=  }}  
{{STRUCTURE_1b0w|  PDB=1b0w  |  SCENE=  }}  


'''Structural comparison of amyloidogenic light chain dimer in two crystal forms with nonamyloidogenic counterparts'''
===Structural comparison of amyloidogenic light chain dimer in two crystal forms with nonamyloidogenic counterparts===




==Overview==
<!--
The most common form of hereditary systemic amyloidosis is familial amyloidotic polyneuropathy associated with single amino acid changes in the plasma protein transthyretin. So far, high resolution structures of only three amyloidogenic variants (Met30, Ser84, Ile122) and one non-amyloidogenic variant (Thr109) have been reported complemented by X-ray fiber diffraction studies and image reconstruction from electron micrographs of amyloid fibrils. To investigate the role of structural factors in this disease, we extended our studies to other transthyretin variants. We report crystallization and structural investigations of three amyloidogenic (Arg10, Ala60, Tyr77) and two non-amyloidogenic variants (Ser6, Met119). The similarity of these structures to normal transthyretin does not give direct clues to the fibril forming process. Since transthyretin amyloid fibrils contain a major fragment starting at position 49, besides the intact molecule, we calculated the solvent accessibility of residue 48. Indeed, all amyloidogenic variants show an increased main chain solvent exposure when compared to normal transthyretin and non-amyloidogenic variants, which can be postulated to result in increased susceptibility to proteolysis. After limited proteolysis, dimers are incapable of reassociation to native tetramers. We present a model for amyloid fibril formation based on formation of fibrils from N-terminal truncated dimers as building blocks.
The line below this paragraph, {{ABSTRACT_PUBMED_9818054}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 9818054 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_9818054}}


==About this Structure==
==About this Structure==
Line 26: Line 30:
[[Category: Amyloid]]
[[Category: Amyloid]]
[[Category: Immunoglobulin]]
[[Category: Immunoglobulin]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 10:56:10 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 18:00:28 2008''

Revision as of 15:00, 30 June 2008

File:1b0w.png

Template:STRUCTURE 1b0w

Structural comparison of amyloidogenic light chain dimer in two crystal forms with nonamyloidogenic counterparts

Template:ABSTRACT PUBMED 9818054

About this Structure

1B0W is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation., Schormann N, Murrell JR, Benson MD, Amyloid. 1998 Sep;5(3):175-87. PMID:9818054

Page seeded by OCA on Mon Jun 30 18:00:28 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1b0w&oldid=575464"